Chesterfield Royal Hospital NHS Foundation Trust became a NHS Foundation Trust in January 2005, providing health services at the Chesterfield Royal Hospital and at other facilities in Chesterfield, Derbyshire, England.

During the past decade, Chesterfield Royal Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chesterfield Royal Hospital" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 2 trials, followed by "Aerovance, Inc." with 1 trials sponsored, "Bayer" with 1 trials sponsored, "Chesterfield and North Derbyshire Royal Hospital" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chesterfield Royal Hospital" #1 collaborator was "British Heart Foundation" with 2 trials as a collaborator, "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator, "Berry Consultants" with 1 trials as a collaborator, "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Chesterfield Royal Hospital" are "Breast Cancer" (3 trials), "Leukemia" (2 trials), "Abscess Anorectal" (1 trials), "Abscess; Anus" (1 trials) and "Anxiety" (1 trials). Many other conditions were trialed in "Chesterfield Royal Hospital" in a lesser frequency.

Most popular intervention types in "Chesterfield Royal Hospital" are "Drug" (10 trials), "Other" (7 trials), "Procedure" (7 trials), "Device" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (2 trials), "fludarabine phosphate" (2 trials), "ARB + DMX-200" (1 trials), "Aerovant" (1 trials) and "Amoxicillin-clavulanate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chesterfield Royal Hospital" are 18 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Chesterfield Royal Hospital". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Chesterfield Royal Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Chesterfield Royal Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".